ストックスクリーナーアプリを入手
3.12
3.41%
-0.11
アフターアワーズ：
3.13
0.010
+0.32%
前日終値:
$3.23
開ける：
$3.2
24時間の取引高:
6.87M
Relative Volume:
1.45
時価総額：
$805.55M
収益：
$427.68M
当期純損益:
$-58.06M
株価収益率:
-13.10
EPS:
-0.2382
ネットキャッシュフロー:
$-37.50M
1週間 パフォーマンス:
-5.74%
1か月 パフォーマンス:
-12.85%
6か月 パフォーマンス:
-50.71%
1年 パフォーマンス:
-37.72%
1日の値動き範囲:
$3.09
$3.205
1週間の範囲:
$3.09
$3.30
52週間の値動き範囲:
$3.09
$8.40
Ardelyx Inc Stock (ARDX) Company Profile
Compare ARDX vs VRTX, MRNA, REGN, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
3.12 | 805.55M | 427.68M | -58.06M | -37.50M | -0.2382 |
VRTX
Vertex Pharmaceuticals Inc
|
485.22 | 122.98B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
216.25 | 86.33B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
753.12 | 77.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
802.64 | 50.47B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.44 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-06-16 | 再開されました | Ladenburg Thalmann | Buy |
| 2026-01-09 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-09-03 | 再開されました | Raymond James | Strong Buy |
| 2025-06-18 | 再開されました | H.C. Wainwright | Buy |
| 2025-05-02 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | 再開されました | Ladenburg Thalmann | Buy |
| 2025-03-04 | 開始されました | BTIG Research | Buy |
| 2024-11-11 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | 開始されました | Leerink Partners | Outperform |
| 2023-12-18 | 開始されました | Raymond James | Strong Buy |
| 2023-09-07 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-25 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | アップグレード | Wedbush | Neutral → Outperform |
| 2022-11-17 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | ダウングレード | Jefferies | Buy → Hold |
| 2021-07-20 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | ダウングレード | Wedbush | Outperform → Neutral |
| 2021-03-23 | 開始されました | Wedbush | Outperform |
| 2021-01-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-10-20 | 再開されました | Citigroup | Buy |
| 2020-02-18 | 再開されました | Jefferies | Buy |
| 2020-02-12 | 開始されました | Citigroup | Buy |
| 2020-02-10 | 開始されました | Cowen | Outperform |
| 2019-04-08 | 開始されました | Piper Jaffray | Overweight |
| 2018-08-24 | 開始されました | Jefferies | Buy |
| 2018-03-19 | 再開されました | Leerink Partners | Outperform |
| 2017-11-29 | 繰り返されました | Citigroup | Buy |
| 2017-11-22 | 繰り返されました | Ladenburg Thalmann | Buy |
| 2017-10-17 | 再開されました | Leerink Partners | Outperform |
| 2016-03-31 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-03-09 | 開始されました | Cantor Fitzgerald | Buy |
| 2016-03-03 | 開始されました | Citigroup | Buy |
すべてを表示
Ardelyx Inc (ARDX) 最新ニュース
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL - GlobeNewswire Inc.
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionARDX - GlobeNewswire Inc.
New Strong Sell Stocks for October 9th - Zacks Investment Research
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionARDX - GlobeNewswire Inc.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionHIMS - GlobeNewswire Inc.
SueWallSt Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026ARDX - Morningstar
SueWallSt Reminds Ardelyx, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 16, 2026ARDX - TradingView
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - PR Newswire
ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ARDX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Ardelyx (NASDAQ: ARDX) Investors of Securities Class Action Lawsuit Deadline on November 16, 2026 - FinancialContent
ARDX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Ardelyx, Inc. Securities LawsuitContact Levi & Korsinsky - PR Newswire
New Strong Sell Stocks for October 7th - Zacks Investment Research
Ardelyx Inc (41X.HM) Stock Price, News, Quote & History - Yahoo! Finance Canada
ARDX DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ardelyx (ARDX) - The National Law Review
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Baidu, Inc. (BIDU), Ardelyx, Inc. (ARDX), and Better Home & Finance Holding Company (BETR) Announced by Holzer & Holzer, LLC - GlobeNewswire Inc.
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Securities Lawsuit Alert: Ardelyx, Inc. (ARDX) InvestorsContact Levi & Korsinsky Before November 16, 2026 - ACCESS Newswire
Class Action Lawsuit Filed: Ardelyx, Inc. (ARDX)Join by November 16, 2026Contact Levi & Korsinsky - ACCESS Newswire
Ardelyx to present hyperphosphatemia research at ASN meeting By Investing.com - Investing.com Nigeria
Ardelyx to present hyperphosphatemia research at ASN meeting By Investing.com - Investing.com South Africa
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionARDX - GlobeNewswire Inc.
Ardelyx to present hyperphosphatemia research at ASN meeting - Investing.com
ARDX Investor Alert: Ardelyx, Inc. Securities Class Action Notice – Contact Levi & Korsinsky - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Ardelyx, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Important Notice to Long-Term Shareholders of Anavex Life - GlobeNewswire
Many of about 550,000 U.S. dialysis patients have high blood phosphate. Ardelyx will present three studies. - Stock Titan
Robbins LLP Urges ARDX Stockholders Who Lost Money Investing in Ardelyx, Inc. to Contact the Firm for Information About Leading the Class Action - FinancialContent
Ardelyx Inc (41X.HM) Income Statement - Yahoo! Finance Canada
Ardelyx (NasdaqGM:ARDX) Stock Forecast & Analyst Predictions - Simply Wall Street
Ardelyx Inc (41X.HM) stock historical prices and data - Yahoo Finance UK
Ardelyx Inc. R (41X.HM) Q1 FY2026 earnings call transcript - Yahoo Finance
Ardelyx Inc. R (41X.HM) Q4 FY2025 earnings call transcript - Yahoo Finance
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit - PR Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionARDX - GlobeNewswire Inc.
Is Ardelyx (ARDX) Undervalued Following Its PM360 Trailblazer Awards? - Simply Wall Street
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Ardelyx Inc (41X.HM) interactive stock chart - Yahoo Finance UK
Ardelyx Inc (41X.HM) income statement - Yahoo Finance UK
November 16, 2026 Deadline Approaching: Join Class Action Against Ardelyx, Inc. (ARDX)Contact Levi & Korsinsky - ACCESS Newswire
ARDX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Ardelyx (AR - The National Law Review
ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026 - TradingView
ARDX Deadline Alert: SueWallSt Reminds Ardelyx, Inc. (ARDX) Investors of Securities Class Action Deadline on November 16, 2026 - PR Newswire
ARDX UPCOMING DEADLINE: Levi & Korsinsky Alerts Ardelyx, Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire
A podcast on gut disorders wins gold at the PM360 awards - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines – ARDX - FinancialContent
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in XTI Aerospace, Inc. of Class Action Lawsuit and Upcoming Deadlines – XTIA - GlobeNewswire Inc.
Debt to equity ratio of Ardelyx, Inc. – HAN:41X - TradingView
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Ardelyx Inc (ARDX) 財務データ
収益
当期純利益
現金流量
EPS
Ardelyx Inc (ARDX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Foster Eric Duane | Officer |
Aug 21 '26 |
Proposed Sale |
4.03 |
11,900 |
47,957 |
0 |
| Bishop John E | Officer |
Aug 21 '26 |
Proposed Sale |
4.03 |
25,500 |
102,765 |
0 |
| Brady James Parker | Officer |
Aug 21 '26 |
Proposed Sale |
4.03 |
19,700 |
79,391 |
0 |
| Brady James Parker | Chief Human Resources Officer |
Aug 21 '26 |
Sale |
3.86 |
15,136 |
58,378 |
245,930 |
| Foster Eric Duane | Chief Commercial Officer |
Aug 21 '26 |
Sale |
3.86 |
8,562 |
33,023 |
409,410 |
| Kelliher Mike | Chief Business Officer |
Aug 21 '26 |
Sale |
3.86 |
7,758 |
29,922 |
349,660 |
| Williams Laura A | Chief Patient Officer |
Aug 21 '26 |
Sale |
3.86 |
10,739 |
41,419 |
367,456 |
| RAAB MICHAEL | President & CEO |
Aug 21 '26 |
Sale |
3.86 |
58,574 |
225,914 |
1,619,792 |
| Hohenleitner Susan | Officer |
Aug 21 '26 |
Proposed Sale |
4.03 |
2,650 |
10,680 |
0 |
| Reilly Joseph James | See Remarks |
Aug 21 '26 |
Sale |
3.86 |
3,982 |
15,358 |
145,854 |
3.78%
大文字化:
|
ボリューム (24 時間):